Immuneering

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Mon, July 3, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Thu, October 12, 2023

Filed a patent for "mek inhibitors for treating cancers associated with a ras mutation" on Fri, March 3, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Mon, April 17, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Fri, June 2, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Fri, June 23, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Wed, October 11, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Wed, October 11, 2023

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Wed, March 13, 2024

Filed a patent for "inhibiting mitogen-activated protein (map)/erk kinase (mek)1 and mek2 and related methods of treatment" on Wed, March 13, 2024

Filed a patent for "inhibiting mitogen-activated protein (map)/erk kinase (mek)1 and mek2 and related methods of treatment" on Thu, April 4, 2024

Filed a patent for "inhibiting mitogen-activated protein (map)/erk kinase (mek)1 and mek2 and related methods of treatment" on Tue, April 9, 2024

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Wed, November 9, 2022

Filed a patent for "mek immune oncology inhibitors and therapeutic uses thereof" on Mon, July 3, 2023